Survival in patients with gastric lymphoma

##plugins.themes.academic_pro.article.sidebar##

Published Oct 27, 2011
Download
pdf
Vol. 89 No. 10 (2011): Issue Oct 2011

##plugins.themes.academic_pro.article.main##

Asma Ouakaa-Kchaou
Service de Gastro-entérologie Hôpital H. Thameur Tunis
Dalila Gargouri
Service de Gastro-entérologie Hôpital H. Thameur Tunis
Héla Elloumi
Asma Kochlef
H Bouzid
Afef Kilani
Malika Romani
Jamel Kharrat
Abdeljabbar Ghorbel

Abstract

Background: Mucosa-associated lymphoid tissue lymphoma is a histological type of marginal zone non-Hodgkin's lymphoma. Its clinical features and prognosis have seldom been reported because of its indolent clinical course.
Aim: To establish prognostic factors that should be considered for the staging and management of this disease.
Methods: Clinical data of 40 pathologically confirmed gastric lymphoma patients, treated during a period of 13 years, were analyzed.
Results: Of the 40 patients, 65% had stage IE - II1E disease and 35% had stage II2E - IV disease. A total of 18 patients received surgeries.Eighteen patients had chemotherapy and 10 patients had Helicobacter Pylori eradication therapy. The complete remission rate after treatment was 50%. The patients were followed up for a median of 26.75 months. The 5-year overall survival rate was 70%. Early stage at presentation, surgery, normal lactic dehydrogenase (LDH) levels and Helicobacter Pylori infection were associated with longer survival in univariate analysis.
Conclusion: This study suggested that surgery might be an important factor predicting the long-term survival of patients with primary gastric lymphoma. Patients with poor prognostic factors should be treated more aggressively.

Keywords:

Primary gastric lymphoma; survival; prognostic factors

##plugins.themes.academic_pro.article.details##

References

  1. Albujar P, Diaz J, Salinas E. Primary gastrointestinal lymphomas: clinical and pathological aspects and survival. Rev Gastroenterol 1995; 45: 832-45.
  2. Brousse N. Le lymphome à petites cellules est-il un pseudolymphome, un lymphome ou une maladie infectieuse ? Ann Path 1994; 14: 206-8.
  3. David L, Martin S, Daniel A. Long term follow-up after curative surgery for early gastric lymphoma. Ann Surg 1996; 223: 53-62.
  4. Balfe P, O'Brian S, Daly P, Reynolds JV. Management of gastric lymphoma. Surgeon 2008; 6: 262-5.
  5. Aozasa K, Ueda T, Kutata A. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphoma. Cancer 1988; 20: 95-9.
  6. Hoshida Y, Kusakabe H, Miwa H, Kasugai T, Ishiguro S. Reassessment of gastric lymphoma in light of the concept of mucosa associated lymphoid tissue lymphoma. Cancer 1997; 80: 1151-9.
  7. Montalban C, Castrillo JM, Abraira V, Serrano M, Bellas C, Piris MA. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6: 355-62.
  8. Ruskone-Fourmestraux A, Pescatore P, Rambaud JC, Lavergne A, Colombel JF, Eugene C. Polypose lymphomateuse digestive. Gastroenterol Clin Biol 1992; 16: 649-55.
  9. Sergui B, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterol 1991;101: 1159-70.
  10. Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high-grade malignancy in relation to the MALT concept. Gut 1996; 39: 556-61.
  11. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
  12. Chandran R, Hemanth R, Harit K, Chatur V. Primary gastrointestinal lymphoma: 30 years experience at the cancer institute, Madras, India. J Surg Oncol 1995; 60: 41-9.
  13. Magid H, Akkad S. Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterol 1994; 106: 846-58.
  14. Morton JE, Leyland HJ, Vaughan H. Primary gastrointestinal non Hodgkin's lymphoma a review of 175 British national lymphoma investigation cases. Br J Cancer 1993;67: 776-82.
  15. Sperenza J, Loranto D, Lezoche E. Primary gastric lymphoma. Hepatogastroenterol 1995; 42: 371-6.
  16. Akaza K, Motoori T, Nakamura S, Koshokawa T, Kitoh K, Futamira N. Clinicopathologic study of primary gastric lymphoma of B-cell phenotype with special reference to lox grade B-cell lymphoma of mucosa associated lymphoid tissue among the Japanese. Pathol Int 1995; 45: 832-45
  17. Baldessera A, Perini F, Frezza G, Neri S. Combined treatment of stage I and II gastric lymphoma. Radio Med 1995; 89: 702-4.
  18. Colucci G, Naglieri E, Maielle E, Marzullo F, Caruso ML, Leo S. Role of prognostic factors in the therapeutic strategy of primary gastric non-Hodgkin's lymphoma. Clin Ter 1998; 149: 25-30.
  19. Flobert C, Cellier C, Landi B, Berger A, Palazzo L. Severe hemorrhagic gastritis of radiation origin. Gastroenterol Clin Biol 1998; 22: 232-4
  20. Liang R, Tood D, Chan TK, Chiu E, Lie A, Kowng YL. Prognostic factors in primary gastrointestinal lymphoma. Hematol Oncol 1995; 13: 153-63.
  21. Parilla P, Garcia-Marcilla JA, Alanso JD, Acosta J, Carrasco L, Sanchez-Bueno F. Prognostic factors in primary gastrointestinal non Hodgkin's lymphoma. Yonsei Med J 1998; 39: 763-7.
  22. Pradella P, Maculotti L, Sesana G. Primary gastric lymphoma: 14 clinical cases. Minerva Chir 1995; 50: 637-41.
  23. Richard K, Valicenti MD, Todd H, Wasserman MD, Kucik NA. Analysis of prognostic factors in localized lymphoma: the importance of Bulk of disease. Int J Rad Oncol Bio Phy 1993; 27: 591-8.
  24. Yasushiro K, Shigo N, Yoshitaka Y. Primary gastric B-cell lymphoma: audit of 82 cases treated wtih surgery and classified according to the concept of mucosa-associated lymphoid tissue lymphoma. World J Surg 2000; 24: 857-62.
  25. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297-303
  26. Rougier P, Azab M, Henry-Amar M, et al. Localisation digestive primitive des lymphomes malins non-Hodgkiniens. Facteurs pronostiques des formes localement étendues : stade II. A propos d'une série de 67 cas. Gastroenterol Clin Biol 1990;14: 626-34.
  27. Walker DM, Freeze R, Roberts J. Treatment of gastric lymphoma. Am Surg 1992; 58: 409-12.
  28. Raderer M, Paul De Boer J. Role of chemotherapy in gastric MALT lymphoma, diffuse large B-cell lymphoma and other lymphomas. Best Pract Res Clin Gastroenterol. 2010; 24: 19-26
  29. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 2000; 119: 1191-202.
  30. Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud JC. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993;105:1662-71.
  31. Vaillant JC, Ruskone-Fourmestraux A, Aegerter P, et al. Management and long-term results of surgery for localized gastric lymphomas. Am J Surg 2000; 179: 216-22.
  32. Danzon A, Belot A, Maynadié M, Remontet L, Dupont AC, Carbonnel F. Incidence and survival of gastric non-Hodgkin's lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM). Acta Oncol 2009;48: 977-83.
  33. David SS, Daniel ED, Thomas A. Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapy. Cancer 1983;52: 2044-8.